Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|11|1|1-7
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.11, Iss.1, 2011-03, pp. : 1-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Pecková M Charvat J Schuck O Hill M Svab P Horackova M
The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. :
Dapagliflozin for the treatment of type 2 diabetes
By Abdul-Ghani Muhammad A DeFronzo Ralph A
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Linagliptin: In Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. :
Metformin ++ saxagliptin for type 2 diabetes
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. :